Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Clever Leaves Holdings Inc

HEXO Corp

Check these 3 marijuana penny stocks out ahead of new cannabis legislation The post Will The Cannabis Legalization Bill Affect Penny Stocks? 3 to Watch  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Will The Cannabis Legalization Bill Affect Penny Stocks? 3 to Watch

Mike Gorenstein had served as chief executive of the Canadian cannabis company until 2020.

Cronos Stock Rises as Founder Gorenstein Returns as CEO

Cronos Group Inc. CRON, +3.74% CRON, +3.62% on Monday named its executive chairman Mike Gorenstein as chairman, president, and CEO of the cannabis company. The move takes effect Monday after Kurt Schmidt retired as CEO.

Cronos Group's Mike Gorenstein returns as CEO

Kurt Schmidt, President and Chief Executive Officer, to Retire Kurt Schmidt, President and Chief Executive Officer, to Retire

Cronos Group Founder Mike Gorenstein Returns as CEO

Aurora Cannabis

Canopy Growth

Tilray Brands

Cannabis Industry Updates and Current Events 2022 The post Cannabis Industry Trends To Watch For In 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Cannabis Industry Trends To Watch For In 2022

Netflix

Take-Two Interactive Software

These falling stocks could be headed even lower this year.

3 Growth Stocks That Could Be Headed for Trouble

The cannabis company's business remains deep in the red despite its strong sales numbers.

Is Cronos a Buy After Reporting 51% Sales Growth in Q4?

A More Equitable Cannabis Industry

Flora Growth Corp

GrowGeneration Corp

Hydrofarm Holdings Group

Incannex Healthcare Inc

Jazz Pharmaceuticals

OrganiGram Holdings Inc.

Village Farms International

The Valens Co

Zynerba Pharmaceuticals

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.

Cannabis Sector Kicks Off March With a Blast of Q4 Earnings

Cronos Group Inc. (CRON) CEO Kurt Schmidt on Q4 2021 Results - Earnings Call Transcript

Cronos Group CRON, +1.13% said Tuesday its fourth-quarter loss increased to $133.89 million, or 36 cents a share, from $111.71 million, or 31 cents a share, in the year-ago quarter. Net revenue increased to $25.8 million from $17.05 million.

Cronos Group loss widens, revenue beats target

Consolidated net revenue increased 59% in Full Year 2021 compared to Full Year 2020

Cronos Group Reports 2021 Fourth Quarter and Full-Year Results

TORONTO, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Fourth Quarter and Full-year Earnings Conference Call on Tuesday, March 1, 2022 at 8:30 a.m. ET. Cronos Group's senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2021 Fourth Quarter and Full-Year Earnings Conference Call on March 1, 2022

Cronos Group Inc.'s (CRON) CEO Kurt Schmidt on Q3 2021 Results - Earnings Call Transcript

OAKLAND, Calif.--(BUSINESS WIRE)---- $CRON #CRON--Gibbs Law Group is investigating potential claims on behalf of Cronos Group investors.

Lost Money in Cronos Group, Inc.?

Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) announced its 2021 third-quarter business results, revealing net revenue of $20.4 million, compared to $11.4 million in the same period of 2020. The increase year-over-year was primarily driven by continued growth in the adult-use market in Canada, increased sales in the Israeli medical cannabis market and increased sales in the U.S. segment.

Cronos Q3 Revenue Grows 79% YoY To $20.4M, Audit Committee Completes Evaluation

Cronos Group CRON, -4.77% CRON, -4.59% said Friday its third-quarter net income fell to $55.1 million, or 21 cents a share, from $95.2 million, or 18 cents a share, in the year-ago period. The latest quarter includes a $132.9 million gain on revaluation of derivative liabilities.

Cronos Group net income falls, launches cost-cutting measures

Completed Audit Committee evaluation and restated Q2 2021 unaudited interim financial statements

Cronos Group Reports 2021 Third Quarter Results

TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Third Quarter Earnings Conference Call on Friday, February 18, 2022 at 8:30 a.m. EST. Cronos Group's senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

Cronos Group Inc. to Hold 2021 Third Quarter Earnings Conference Call on February 18, 2022

On November 9, 2021, the company announced that it applied for a management cease trade order with the applicable securities regulatory authorities in Canada on the basis that the company would be unable to file its Quarterly Report on Form 10-Q for the period ended September 30, 2021 with the U.S. Securities and Exchange Commission, together with its corresponding quarterly filings in Canada, by the applicable filing deadlines. The MCTO was issued on November 16, 2021 and restricts all trading in securities of the company, whether direct or indirect, by the CEO and CFO of the company until two full business days following the filing of therequired filings and the MCTO has been revoked.

Cronos Group Provides Bi-Weekly MCTO Status Update

Will Canadian Pot Stocks See Upside In Q1 2022? The post Canadian Marijuana Stocks On The Nasdaq For Your Watchlist In February 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks On The Nasdaq For Your Watchlist In February 2022

Columbia Care Inc. and Trulieve Cannabis Corp. announced separate debt deals in recent days as cannabis companies turn away from issuing stock to raise capital in the face of weak share prices.

Cannabis Watch: Cannabis companies pivot to debt to raise capital as stock prices lag

Cannabis industry expert Alan Brochstein on 2022 catalysts.

Alan Brochstein On Cannabis Investing In 2022 (Video Transcript)

Inovio Pharmaceuticals

These companies wouldn't be worth a second look, even in a less volatile market.

2 Stocks to Avoid Like the Plague in 2022

Jefferies upgraded two Canadian cannabis stocks on Thursday and reduced his price target on a third, remaining most bullish on buy-rated OrganiGram Holdings Inc., which it said is “really starting to hit its stride.”

News for Cronos Group Stock (CRON)